EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploring the Impact of Personality Traits on Response to Anti-CGRP Therapies: Insights from a Pilot Study

Chiara Zilli iD, Giada Giuliani iD, Giulio Tancredi, Mariangela Fratino iD, Benedetta Pitzalis, Marta Altieri

NeuroSci · 06.07.2026 · 7 (4) · 77

DOI: 10.3390/neurosci7040077 ↗

Kurz gefasst

Fachartikel in der Zeitschrift NeuroSci, online erschienen am 06.07.2026. Verfasst von Chiara Zilli und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Neurosciences, Sapienza University of Rome, 00185 Rome, Italy. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Monoclonal antibodies targeting the calcitonin gene-related peptide (CGRP) pathway represent an effective preventive treatment for chronic migraine, including in patients with multiple prior therapeutic failures. However, a substantial proportion of patients exhibit a suboptimal or delayed response. The role of personality traits in modulating treatment response remains poorly understood.

Methods

In this prospective observational study, adults with chronic migraine received anti-CGRP monoclonal antibodies and were followed for 12 months. Monthly headache days (MHDs), monthly acute medication use (MAM), and disability scores (MIDAS and HIT-6) were recorded at baseline and at 3, 6, and 12 months. Responders were defined as patients achieving a ≥50% reduction in monthly headache days (MHDs) compared with baseline. Changes in disability measures were evaluated as secondary clinical outcomes. Personality traits were assessed using the Millon Clinical Multiaxial Inventory-III.

Results

Thirty-eight patients were included, of whom 71% had medication overuse headaches. Responder rates increased over time (31.6% at 3 months and 39.5% at 12 months). Histrionic traits (37.5% vs. 6.7%, p = 0.048) and dysthymic features (21.4% vs. 0%, p = 0.046) were significantly more prevalent among non-responders.

Conclusions

Histrionic and dysthymic personality features were associated with a lower likelihood of response to anti-CGRP therapy in patients with chronic migraine. Given the exploratory design, limited sample size, and absence of correction for multiple comparisons, these findings should be considered preliminary and hypothesis-generating. Further studies in larger cohorts are needed to confirm these observations.

Schlagwörter

Stichwörter der Autor:innen

CGRP monoclonal antibodieschronic migrainepersonality traitstreatment response

Autor:innen und Institutionen

  • Department of Human Neurosciences, Sapienza University of Rome, 00185 Rome, Italy.
  • Department of Pediatrics, University of Rome "Tor Vergata", 00133 Rome, Italy.

ORCID-Profile: Chiara Zilli, Giada Giuliani, Mariangela Fratino

Zitieren

APA

Zilli, C., Giuliani, G., Tancredi, G., Fratino, M., Pitzalis, B., & Altieri, M. (2026). Exploring the Impact of Personality Traits on Response to Anti-CGRP Therapies: Insights from a Pilot Study. NeuroSci, 7(4), 77. https://doi.org/10.3390/neurosci7040077

Vancouver

Zilli C, Giuliani G, Tancredi G, Fratino M, Pitzalis B, Altieri M. Exploring the Impact of Personality Traits on Response to Anti-CGRP Therapies: Insights from a Pilot Study. NeuroSci. 2026;7(4):77. doi:10.3390/neurosci7040077

BibTeX
@article{Zilli2026,
  author = {Zilli, Chiara and Giuliani, Giada and Tancredi, Giulio and Fratino, Mariangela and Pitzalis, Benedetta and Altieri, Marta},
  title = {Exploring the Impact of Personality Traits on Response to Anti-CGRP Therapies: Insights from a Pilot Study},
  journal = {NeuroSci},
  year = {2026},
  volume = {7},
  number = {4},
  pages = {77},
  doi = {10.3390/neurosci7040077}
}
Kostenlos starten →